Latest Posts
About This Stock
More About This Stock
Watch
Read
Watch
Read
This Dirt-Cheap Stock Looks Attractive And Pays A Market-Smashing Yield
Video By:
Jason Fieber
Monday, May 16, 2022 6:37 AM EDT
After all, if you got a health problem, you're going to do whatever is necessary to get treatment. Demand for these products is inelastic and growing. And that means a long runway for revenue, profit, and dividend growth.
In this video: GILD
Stocks Are Undervalued
Article By:
Dividend Power
Sunday, May 15, 2022 7:57 AM EDT
The bear growled this past week as the S&P 500 Index skirted the (-20%) threshold. But Friday the markets bounced back, much to investors’ relief. The Index is still in a correction, although that may change next week if more bad news arrives.
Pummeled! These 5 Dividend Growth Stocks Are Down Big Time From Their 52 Week Highs
Video By:
Jason Fieber
Monday, April 11, 2022 6:45 AM EDT
2022 has been nuts, right? After investing for more than a decade, I've never seen this kind of sustained daily volatility before. But, as always, I see short-term volatility as a long-term opportunity.
High Dividend 50: Gilead Sciences
Article By:
SureDividend
Friday, March 18, 2022 5:38 PM EDT
Gilead is offering an all-time high dividend yield of 5.0% and is trading at a forward price-to-earnings ratio of 9.1. Unfortunately, there are good reasons behind these seemingly attractive features of the stock.
In this article: GILD
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.
www.talkmarkets.com/.../interview-with-vitality-biopharma-inc
Not a lot of info on the company though.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I think $GILD will rebound. This isn't the only product they have in their pipeline.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.
Gilead Sciences Receives Canadian Approval For HIV Drug
The opening up of this market for #GileadSciences should bode well for the stock $GILD.
Gilead Sciences: Cheap Growth Or Value Trap?
Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD
3 Cult Stocks To Avoid In 2015
Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.
3 Cult Stocks To Avoid In 2015
Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.
3 Cult Stocks To Avoid In 2015
I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.